2025.0217
[News] HIRA to Unveil Diabetic Care Status in commemoration of World Diabetes Day
HIRA to Unveil Diabetic Care Status in commemoration
of World Diabetes Day
- 2023 diabetic patients of 3,828,682 people, taking up 7.4% of entire population -
<Main Content>
○ [Diabetes] 2023 diabetic patients of 3,828,682 people, per-capita medical fee of 307,289 won, and combined medical fee of 1.176.5 billion won
- Patients number up by 18.6% (annual average 4.4%) (up by 19.6% for men, 17.3% for women)
- Annual average 7.1% up in recent 5 year-national insurance medical fee combination; and 5.9% up in diabetes
- Disorders of lipoprotein metabolism and other lipidemias accounting for 39.8% of the highest in frequent comorbidities of diabetes
- Diabetic patient accompanied with hypertension constituting 48.2%
□ The Health Insurance Review and Assessment Service (HIRA), led by President Kang Jung-Gu, unveiled diabetic care status in the recent 5 years (2019-2023) on November 14, 2024, in commemoration of World Diabetes World.
□ The analysis of recent 5-year diabetic care progress presented an increase (2019-2023): by 18.6% (annual average 4.4%) in patient numbers; by 25.7% (annual average 5.9%) in medical fees; and in the proportion of men in gender ratio.
○ The number of male patients rose 19.6% (annual average 4.6%) for half a decade, with a 30.1% rise of annually combined medical fees (annual average 6.8%).
- patients number: 1,794,777 people (2019) to 2,146,381 people (2023)
- combined medical fees: 505.3 billion won (2019) to 657.2 billion won (2023)
○ The proportion of female patients numbers grew by 17.3% for 5 years (annual average 4.1%), along with a 20.6% increase in the annual combination of medical fees (annual average 4.8%).
- patients number: 1,433,783 people (2019) to 1,682,301 people (2023)
- combined medical fees: 430.4 billion won (2019) to 519.3 billion won (2023)
[Table 1] Gender-based diabetic care status in recent 5 years (2019-2023)
(Unit: people, billion won, won, %)
Classification
2019
2020
2021
2022
2023
Increase & Decrease
Annual
average
2023
over 2019
Diabetes
Total
No. of
Patients
3,228,560
3,348,237
3,569,294
3,697,999
3,828,682
▲ 4.4
▲ 18.6
Combined
medical fees
9,357
9,719
10,549
11,038
11,765
▲ 5.9
▲ 25.7
Per-capita
medical fee
289,833
290,271
295,547
298,496
307,289
▲ 1.5
▲ 6.0
Male
No. of
Patients
1,794,777
1,868,692
1,988,924
2,065,644
2,146,381
▲ 4.6
▲ 19.6
Combined
medical fees
5,053
5,321
5,825
6,127
6,572
▲ 6.8
▲ 30.1
Per-capita
medical fee
281,553
284,747
292,873
296,623
306,198
▲ 2.1
▲ 8.8
Female
No. of
Patients
1,433,783
1,479,545
1,580,370
1,632,355
1,682,301
▲ 4.1
▲ 17.3
Combined
medical fees
4,304
4,398
4,724
4,911
5,193
▲ 4.8
▲ 20.6
Per-capita
medical fee
300,196
297,248
298,913
300,866
308,681
▲ 0.7
▲ 2.8
□ The analysis of 5-year diabetic care progress per in-patient or out-patient (2019-2023) resulted in a 12.5% decrease (annual average 3.3%) in in-patient claim cases; and a 9.6% rise of out-patient cases.
○ In-hospital patients numbers fell 6.1% (annual average 1.6%) for the last 5 years, 3.0% up from annual combined medical fees (annual average 0.7%).
- patients number: 94,248 people (2019) to 88,465 people (2023)
- combined medical fees: 283.8 billion won (2019) to 292.4 billion won (2023)
- per-case medical fee: 1,677,344 won (2019) to 1,975,510 won (2023)
○ Out-hospital patients numbers climbed 18.7% (annual average 4.4%) for half a decade, 35.6% up from annual combined medical fees (annual average 7.9%).
- patients number: 3,210,072 people (2019) to 3,810,377 people (2023)
- combined medical fees: 651.9 billion won (2019) to 884.1 billion won (2023)
- per-case medical fee: 28,658 won (2019) to 35,451 won (2023)
[Table 2] Diabetic care status by in-patient or out-patient in recent 5 years (2019-2023)
(Unit: people, case, billion won, won, %)
Classification
2019
2020
2021
2022
2023
Increase & Decrease
Annual
average
2023
over 2019
Diabetes
In-patient
No. of Patients
94,248
86,322
89,380
95,789
88,465
▼ 1.6
▼ 6.1
No. of claims
169,224
155,367
154,635
162,080
148,036
▼ 3.3
▼ 12.5
Total claims
2,838
2,772
2,785
2,771
2,924
▲ 0.7
▲ 3.0
Per-capita
medical fee
3,011,701
3,210,688
3,115,837
2,892,984
3,305,789
▲ 2.4
▲ 9.8
Per-case
medical fee
1,677,344
1,783,860
1,800,973
1,709,748
1,975,510
▲ 4.2
▲ 17.8
Out-patient
No. of Patients
3,210,072
3,330,501
3,550,138
3,674,638
3,810,377
▲ 4.4
▲ 18.7
No. of claims
22,747,017
23,109,956
24,275,470
24,531,986
24,937,675
▲ 2.3
▲ 9.6
Total claims
6,519
6,947
7,764
8,267
8,841
▲ 7.9
▲ 35.6
Per-capita
medical fee
203,078
208,600
218,696
224,980
232,015
▲ 3.4
▲ 14.2
Per-case
medical fee
28,658
30,063
31,983
33,700
35,451
▲ 5.5
▲ 23.7
□ Taking the status of patients number against the population by age for 5 years (2019-2023) into consideration, it displayed that more than 15 people among 100 in their 60s or older were diagnosed with diabetes, with age groups in their 20s or younger showing a considerable increase in the patient rate.
○ The age groups who were frequented by the diagnosis of diabetics in 2023 are the following: 21.79% in their 70s (864,383 people); 18.46% in their 80s or older (434,449 people); and 16.4% in their 60s(1,251,421 people) in order.
[Table 3] Diabetic care status by age in recent 5 years (20192023)
(Unit: people, %)
Classification
2019
2020
2021
2022
2023
Increase & decrease
in patient ratio
No. of Patients
(Patients ratio)
No. of Patients
(Patients ratio)
No. of Patients
(Patients ratio)
No. of Patients
(Patients ratio)
No. of Patients
(Patients ratio)
Annual average
2023
aginst 2019
Subtotal
3,228,560
3,348,237
3,569,294
3,697,999
3,828,682
▲ 4.4
▲ 18.6
(6.23)
(6.46)
(6.91)
(7.19)
(7.46)
Under
in their 10s
978
907
1,146
1,153
1,231
▲ 5.9
▲ 25.9
(0.02)
(0.02)
(0.03)
(0.03)
(0.04)
In their 10s
10,395
10,037
12,697
12,612
12,863
▲ 5.5
▲ 23.7
(0.21)
(0.21)
(0.27)
(0.27)
(0.28)
In their 20s
32,735
35,327
41,545
42,772
43,568
▲ 7.4
▲ 33.1
(0.48)
(0.52)
(0.62)
(0.67)
(0.70)
In their 30s
119,580
121,668
131,463
131,823
133,069
▲ 2.7
▲ 11.3
(1.69)
(1.77)
(1.96)
(1.99)
(2.02)
In their 40s
378,482
381,586
401,452
406,713
409,512
▲ 2.0
▲ 8.2
(4.51)
(4.60)
(4.92)
(5.04)
(5.17)
In their 50s
846,206
852,789
876,797
880,337
887,344
▲ 1.2
▲ 4.9
(9.76)
(9.86)
(10.15)
(10.22)
(10.20)
In their 60s
993,584
1,058,852
1,153,081
1,209,388
1,251,421
▲ 5.9
▲ 26.0
(15.74)
(15.70)
(16.09)
(16.34)
(16.40)
In their 70s
740,981
764,773
799,248
838,291
864,383
▲ 3.9
▲ 16.7
(20.61)
(20.68)
(21.51)
(21.91)
(21.79)
In their 80s
or older
299,964
323,781
359,354
407,765
434,449
▲ 9.7
▲ 44.8
(15.91)
(16.16)
(17.05)
(18.07)
(18.46)
* No. of patients is the value without the same person duplication. Without consideration of it, duplication can transpire.
* Rate of patients is the ratio of patients against age-specific population.
□ In light of frequent comorbidities of diabetes in 2023, such order of frequency came as: 39.8% (1,524,737 people) of disorders of lipoprotein metabolism and other lipidemias, 33.7% (1,290,924 people) of essential(primary) hypertension, and 3.0% (113,707 people) of other diseases of liver.
[Table 4] The care status of frequent comorbidities of diabetes(top 5)
(Unit: people, %)
Disease
Name of Disease
2019
2020
2021
2022
2023
No. of patients
Ratio
E78
Disorders of lipoprotein
metabolism
and other lipidemias
1,179,430
1,254,736
1,358,283
1,439,130
1,524,737
39.8
I10
Essential(primary)
hypertension
1,064,640
1,120,579
1,193,845
1,240,941
1,290,924
33.7
K76
Other diseases of liver
117,045
118,352
121,890
116,657
113,707
3.0
K21
Gastro-oesophageal
reflux
97,758
104,256
109,207
106,091
105,179
2.7
G63
Polyneuropathy in diseases
classified elsewhere
95,447
93,370
94,718
91,465
91,708
2.4
* Comorbidity is based upon secondary diagnosis.
** Frequent comorbidity order makes use of 2023 patients number.
*** The proportion is the ratio of diabetic patients number against patients number with comorbidity of such disease.
○ Recent 5 years (2019-2023) record showed that the number of patients with hypertension diseases in diabetes rose 23.1% (annual average 5.3%), and annual combined medical fees 24.5% (annual average 5.6%).
- patients number: 1,499,308 people (2019) to 1,845,265 people (2023)
- combined medical fees: 440.7 billion won (2019) to 548.7 billion won (2023)
- per-capita medical fee: 293,938 won (2019) to 297,355 won (2023)
○ Recent 5 years (2019-2023) record indicated that the number of patients with cardiovascular diseases in diabetes rose 14.8% (annual average 3.5%), and annual combined medical fees 24.1% (annual average 5.5%).
- patients number: 223,647 people (2019) to 256,801 people (2023)
- combined medical fees: 88 billion won (2019) to 109.1 billion won (2023)
- per-capita medical fee: 393,279 won (2019) to 424,935 won (2023)
[Table 5] Diabetic care status concurrently claimed for hypertension and cardiovascular diseases in recent 5 years (2019-2023)
(Unit: people, billion won, won, %)
Classification
2019
2020
2021
2022
2023
Increase & decrease
Annual average
2023
against 2019
Diabetes
& Hypertension
No. of Patients
1,499,308
1,588,193
1,685,847
1,763,369
1,845,265
▲ 5.3
▲ 23.1
Combined
medical fees
4,407
4,571
4,932
5,136
5,487
▲ 5.6
▲ 24.5
Per-capita
medical fees
293,938
287,828
292,567
291,273
297,355
▲ 0.3
▲ 1.2
Diabetes &
Cardiovascular diseases
No. of Patients
223,647
231,153
244,332
248,326
256,801
▲ 3.5
▲ 14.8
Combined
medical fees
880
922
982
999
1,091
▲ 5.5
▲ 24.1
Per-capita
medical fees
393,279
399,055
401,885
402,228
424,935
▲ 2.0
▲ 8.0
* Hypertension (secondary diagnosis):I10-I15 (Korean Standard Classification of Diseases (2020) by the National Statistical Office)
* Cardiovascular disease (secondary diagnosis): I20~I25, I42~I43, and I50~I52 (Korean Standard Classification of Diseases (2020) by the National Statistical Office)
□ Director General of the Big Data Department said “Diabetic care status of recent 5 years explained that most of the patients are in their 40s or older, and yet there is a rising rate of patients in their 20s or younger, thereby calling for entire age groups to do a regular checkup to identify diabetes early and control it.”
○ The HIRA portal provides the review result of medical institutions for diabetes, furnishing information of regional diabetic care status via the healthcare open system.
※ Data Analysis Criteria
○ Jan 2019-Dec 2023 based upon care-given day of national insurance
(reflecting Jan 2019-Apr 2024 review result)
○ Primary diagnosis of Diabetes ((E10~E14), secondary diagnosis of hypertension (I10~I15), secondary diagnosis of cardiovascular diseases (I20~I25, I42~I43, I50~I52)
※ Korean Standard Classification of Diseases (2020) of National Statistical Office, save pharmacies and oriental clinics
○ Disease-specific status came on the back of claim data in which a patient was granted a primary diagnosis, just with his or her complaining and symptoms, by a medical institution, while the diagnosis was uncertain along the way, likely differing from final definite diagnosis.
○ Age is measured on a basis of international age at the medically serviced time.
○ Patients number is the value without duplication of the same patient in a category, and yet duplication can occur when it just adds up the value of other category: for instance, a patient’s age was changed in the course of medical procedures and then each different age is used for the calculation of patients number.
